Skip to main content
. Author manuscript; available in PMC: 2010 Sep 2.
Published in final edited form as: Endocrinology. 2002 Sep;143(9):3414–3426. doi: 10.1210/en.2001-211215

Fig. 7.

Fig. 7

Competition assays with an AP-1 consensus oligonucleotide. Radioactive labeled probe (3 fm) and 10-, 50-, 100-, or 200-fold molar excess of unlabeled competitor were added simultaneously to 2 μ g nuclear extract from LβT4 cells obtained as described in Materials and Methods. The competitors were the unlabeled probe (−163), unlabeled probe with a mutation in the putative AP-1 site (−163M), and an AP-1 consensus oligonucleotide.